- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02904785
Extracorporeal Focused Shock Wave Therapy for Primary Knee Osteoarthritis
The Efficacy of Extracorporeal Focused Shock Wave Therapy for Patients With Primary Knee Osteoarthritis
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study is a placebo controlled Randomized Clinical Trial (RCT) in which the primary outcome is to determine whether Extracorporeal Focused Shock Wave Therapy (ESWT) reduces knee pain comparing the VAS at baseline and one month after the end of the treatment. Function assessment and progression of pain along the treatment are the secondary outcomes. Function will be assessed with the Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC), the Lequesne's Algofunctional Questionnaire for Osteoarthritis of Knee (Lequesne) and the Timed up and Go (TUG).
The ESWT applications will be performed once a week for four consecutive weeks, the patients will be assessed for pain and function before the beginning of the treatment and one week after every application of the ESWT.
The treatment groups will be randomized. The allocation of the patients is sealed and will not be disclosed to the patients nor to the evaluators.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Fase 2
Kontakter og lokationer
Studiesteder
-
-
-
Sao Paulo, Brasilien, 04116-030
- Rekruttering
- Centro de Pesquisa Clínica do Instituto de Medicina Física e Reabilitação do HCFMUSP
-
Kontakt:
- Fabíola Cavalieri, MD
- Telefonnummer: 55-11-99212-3999
- E-mail: fabiola.cavalieri@hc.fm.usp.br
-
Kontakt:
- Artur C Santos
- Telefonnummer: 55-11-5180-7897
- E-mail: artur.santos@hc.fm.usp.br
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Clinical and radiologic diagnosis of primary knee osteoarthritis (Kellgren & Lawrence I, II or III);
- Capability to understand the Informed Consent Form;
- Chronic pain for at least 3 months prior to inclusion, measured by VAS. (VAS 4 or above);
- Absence of skin injures, infections or tumor in the target knee;
- Availability to comply with the visits.
Exclusion Criteria:
- History of spinal cord stenosis or clinical symptoms of lumbar radiculopathy;
- History or onset neurological diseases;
- Generalized pain or fibromyalgia;
- Inability to walk;
- History of knee surgery in the target knee;
- Secondary causes of osteoarthritis;
- Use of statins and quinolones in the previous year;
- Uncontrolled and ongoing psychiatric diseases;
- Invasive knee treatments with hyaluronic acid infusion, corticosteroids and anaesthetics, in the target knee, up to 6 months previous to study inclusion.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Extracorporeal Shock Waves
Focused shock waves delivered by an electromagnetic generator with a focus of 5.0cm deep on the affected knee in three different positions.
A total of 7000 pulses will be delivered on a weekly session for four weeks.
|
Patients receive instructions for physical activities for strengthening of femoral quadriceps and stretching of hamstring muscles.
|
|
Sham-komparator: Sham Extracorporeal Shock Waves
Sham focused shock waves delivered by an electromagnetic generator on the affected knee in three different positions.
A total of 7000 pulses will be delivered on a weekly session for four weeks.
A foam will be placed in the probe as to stop the energy to be transmitted to the patient's knee, so no focused shockwaves will be delivered.
|
Patients receive instructions for physical activities for strengthening of femoral quadriceps and stretching of hamstring muscles.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Knee Pain after one month
Tidsramme: One month
|
Mean change in Visual Analogue Scale (VAS) score one month after the end of the treatment compared to baseline.
|
One month
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Knee pain progression
Tidsramme: One week after each of four weekly ESWT applications
|
Mean change in VAS score one week after each application compared to baseline.
|
One week after each of four weekly ESWT applications
|
|
Knee Pain after three months
Tidsramme: Three months
|
Mean change in VAS score three months after the end of the treatment compared to baseline.
|
Three months
|
|
Lequesne Knee Function progression
Tidsramme: One week after each of four weekly ESWT applications
|
Mean change in Lequesne score one week after each application compared to baseline.
|
One week after each of four weekly ESWT applications
|
|
Lequesne Knee Function after three months
Tidsramme: Three months
|
Mean change in Lequesne three months after the end of the treatment compared to baseline.
|
Three months
|
|
WOMAC Knee Function progression
Tidsramme: One week after each of four weekly ESWT applications
|
Mean change in WOMAC score one week after each application compared to baseline.
|
One week after each of four weekly ESWT applications
|
|
TUG Knee Function progression
Tidsramme: One week after each of four weekly ESWT applications
|
Mean change in TUG score one week after each application compared to baseline.
|
One week after each of four weekly ESWT applications
|
|
WOMAC Knee Function after three months
Tidsramme: Three months
|
Mean change in WOMAC score three months after the end of the treatment compared to baseline.
|
Three months
|
|
TUG Knee Function after three months
Tidsramme: Three months
|
Mean change in TUG score three months after the end of the treatment compared to baseline.
|
Three months
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Linamara R Battistella, PhD, MD, University of Sao Paulo
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 54013616.1.0000.0068
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Unilateral primær slidgigt i knæet
-
Maxx Orthopedics IncRekrutteringKnogletab | Periprotetiske frakturer | Infektion | Aseptisk Løsning | MCL - Medial Collateral Ligament Rupture of the KneeForenede Stater
Kliniske forsøg med Extracorporeal Shock Waves
-
Washington University School of MedicineAfsluttetUrolithiasisForenede Stater
-
Beni-Suef UniversityRekruttering
-
Istinye UniversityAfsluttetSkulderimpingementsyndrom | Ekstrakorporal chokbølgeterapiTyrkiet (Türkiye)
-
The International Alliance of UrolithiasisUkendt
-
Ankara City Hospital BilkentAfsluttetAchilles tendinopati (at)Tyrkiet (Türkiye)
-
General Hospital of Shenyang Military RegionAfsluttet
-
Rennes University HospitalAfsluttet
-
Advance Shockwave Technology GmbHUkendtNyrestenForenede Stater
-
General Hospital of Shenyang Military RegionAfsluttet
-
Kirsehir Ahi Evran UniversitesiRekrutteringSeneskade - HåndTyrkiet (Türkiye)